Kestrel Group Reports Third Quarter 2025 Financial Results

Go back to Kestrel Group Reports Third Quarter 2025 Financial Results
KING PHARMACEUTICALS (NASDAQ: KG) Delayed: 7.60 --0 (-0%)
Previous Close $7.60    52 Week High $14.26 
Open $7.60    52 Week Low $7.18 
Day High $7.60    P/E 22.35 
Day Low $7.60    EPS $0.34 
Volume